IDEXX Laboaratories, Inc. Form 8-K (4-21-03)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 21, 2003

IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

Delaware		000-19271		01-0393723
(State or other jurisdiction of incorporation or organization)		(Commission file number)		(I.R.S. Employer Identification No.)

One IDEXX Drive, Westbrook, Maine		04092
(Address of principal executive offices)		(Zip Code)

(207) 856-0300
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(a) Not applicable.

(b) Not applicable.

99.1 Press release of the Company dated April 21, 2003.

Item 9. Regulation FD Disclosure (Information furnished pursuant to Item 12, “Disclosure of
Results of Operations and Financial Condition”).

On April 21, 2003, IDEXX Laboratories, Inc. (the “Company”) issued a press release announcing earnings results for the quarter ended March 31, 2003. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with the procedural guidance in SEC Release No. 33-8216, the information in this Form 8-K and the Exhibit attached hereto is being furnished under “Item 9. Regulation FD Disclosure” rather than under “Item 12. Disclosure of Results of Operations and Financial Condition.” The information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: April 21, 2003	IDEXX LABORATORIES, INC.

	By: /s/ Merilee Raines
	Merilee Raines Vice President, Finance and Treasurer (Principal Financial and Accounting Officer)

EXHIBIT INDEX

Exhibit No. Description of Exhibit

99.1 Press Release of the Company dated April 21, 2003.